RESEARCH-USE BIOSIMILAR ANTIBODY
Ravulizumab
Monoclonal antibody · IgG2
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
TARGETC5
YMonoclonal antibody
CATALOGSC-BS-237
CATALOG NUMBERSC-BS-237
MOLECULAR WEIGHTApprox. 145.8 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Ravulizumab is a recombinant research-use antibody directed against C5.